This week, we're sitting down with John Faragon to discuss the BRIGHTE study, what it can tell us about fostemsavir, and why it's so important that this study was conducted for five years.
--
Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=AQX7941)
--
Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes.
--
Check out our free online courses: www.necaaetc.org/rise-courses
--
Download our HIV mobile apps:
Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=US
Apple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691
